Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.365
+0.025 (1.87%)
Jun 26, 2026, 2:08 PM EDT - Market open
Cibus Employees
Cibus had 118 employees as of December 31, 2025. The number of employees decreased by 41 or -25.79% compared to the previous year.
Employees
118
Change (1Y)
-41
Growth (1Y)
-25.79%
Revenue / Employee
$36,322
Profits / Employee
-$859,500
Market Cap
104.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 118 | -41 | -25.79% | 118 | 0 |
| Dec 31, 2024 | 159 | -24 | -13.11% | 157 | 2 |
| Dec 31, 2023 | 183 | 135 | 281.25% | 183 | 0 |
| Dec 31, 2022 | 48 | -7 | -12.73% | 48 | 0 |
| Dec 31, 2021 | 55 | -4 | -6.78% | 55 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Alps Group | 93 |
| Pelthos Therapeutics | 92 |
| Fortress Biotech | 78 |
| Verrica Pharmaceuticals | 76 |
| Vivani Medical | 42 |
| Aardvark Therapeutics | 40 |
| Cue Biopharma | 29 |
| Oncolytics Biotech | 29 |
CBUS News
- 9 days ago - Cibus Transcript: Sidoti Small-Cap Virtual Investor Conference - Transcripts
- 9 days ago - Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus - GlobeNewsWire
- 17 days ago - Cibus names Craig Wichner as CEO - TheFly
- 17 days ago - Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation - GlobeNewsWire
- 24 days ago - Cibus Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Cibus files $200M mixed securities shelf - TheFly
- 6 weeks ago - Cibus Registration statement: Registration filing - Filings
- 6 weeks ago - Cibus Earnings Call Transcript: Q1 2026 - Transcripts